Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Evaluation of Acanthamoeba myosin-IC as a potential therapeutic target.

Martín-Navarro CM, Lorenzo-Morales J, López-Arencibia A, Reyes-Batlle M, Piñero JE, Valladares B, Maciver SK.

Antimicrob Agents Chemother. 2014 Apr;58(4):2150-5. doi: 10.1128/AAC.01199-13. Epub 2014 Jan 27.

PMID:
24468784
[PubMed - in process]
2.

Therapeutic potential of a combination of two gene-specific small interfering RNAs against clinical strains of Acanthamoeba.

Lorenzo-Morales J, Martín-Navarro CM, López-Arencibia A, Santana-Morales MA, Afonso-Lehmann RN, Maciver SK, Valladares B, Martínez-Carretero E.

Antimicrob Agents Chemother. 2010 Dec;54(12):5151-5. doi: 10.1128/AAC.00329-10. Epub 2010 Sep 20.

PMID:
20855732
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and application of statins as a novel effective therapeutic approach against Acanthamoeba infections.

Martín-Navarro CM, Lorenzo-Morales J, Machin RP, López-Arencibia A, García-Castellano JM, de Fuentes I, Loftus B, Maciver SK, Valladares B, Piñero JE.

Antimicrob Agents Chemother. 2013 Jan;57(1):375-81. doi: 10.1128/AAC.01426-12. Epub 2012 Oct 31.

PMID:
23114753
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Myosin VI is required for targeted membrane transport during cytokinesis.

Arden SD, Puri C, Au JS, Kendrick-Jones J, Buss F.

Mol Biol Cell. 2007 Dec;18(12):4750-61. Epub 2007 Sep 19.

PMID:
17881731
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.

Visvesvara GS, Moura H, Schuster FL.

FEMS Immunol Med Microbiol. 2007 Jun;50(1):1-26. Epub 2007 Apr 11. Review.

PMID:
17428307
[PubMed - indexed for MEDLINE]
6.

In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts.

Debnath A, Tunac JB, Silva-Olivares A, Galindo-Gómez S, Shibayama M, McKerrow JH.

Antimicrob Agents Chemother. 2014 Mar;58(3):1523-8. doi: 10.1128/AAC.02254-13. Epub 2013 Dec 23.

PMID:
24366747
[PubMed - in process]
7.
8.

Glycogen phosphorylase in Acanthamoeba spp.: determining the role of the enzyme during the encystment process using RNA interference.

Lorenzo-Morales J, Kliescikova J, Martinez-Carretero E, De Pablos LM, Profotova B, Nohynkova E, Osuna A, Valladares B.

Eukaryot Cell. 2008 Mar;7(3):509-17. doi: 10.1128/EC.00316-07. Epub 2008 Jan 25.

PMID:
18223117
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Role of carbohydrate-mediated adherence in cytopathogenic mechanisms of Acanthamoeba.

Cao Z, Jefferson DM, Panjwani N.

J Biol Chem. 1998 Jun 19;273(25):15838-45.

PMID:
9624184
[PubMed - indexed for MEDLINE]
Free Article
10.

Rho/Rho-dependent kinase affects locomotion and actin-myosin II activity of Amoeba proteus.

Kłopocka W, Redowicz MJ.

Protoplasma. 2004 Oct;224(1-2):113-21.

PMID:
15726816
[PubMed - indexed for MEDLINE]
11.

Dynamic localization of myosin-I to endocytic structures in Acanthamoeba.

Ostap EM, Maupin P, Doberstein SK, Baines IC, Korn ED, Pollard TD.

Cell Motil Cytoskeleton. 2003 Jan;54(1):29-40.

PMID:
12451593
[PubMed - indexed for MEDLINE]
12.

Peptide maps of the myosin isoenzymes of Acanthamoeba castellanii.

Gadasi H, Maruta H, Collins JH, Korn ED.

J Biol Chem. 1979 May 10;254(9):3631-6.

PMID:
429373
[PubMed - indexed for MEDLINE]
Free Article
13.

Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.

Martín-Navarro CM, López-Arencibia A, Arnalich-Montiel F, Valladares B, Piñero JE, Lorenzo-Morales J.

Graefes Arch Clin Exp Ophthalmol. 2013 Sep;251(9):2111-7. doi: 10.1007/s00417-013-2371-y. Epub 2013 May 19.

PMID:
23686225
[PubMed - indexed for MEDLINE]
14.

Inhibition of contractile vacuole function in vivo by antibodies against myosin-I.

Doberstein SK, Baines IC, Wiegand G, Korn ED, Pollard TD.

Nature. 1993 Oct 28;365(6449):841-3.

PMID:
8413668
[PubMed - indexed for MEDLINE]
15.

Characterization of a serine proteinase mediating encystation of Acanthamoeba.

Moon EK, Chung DI, Hong YC, Kong HH.

Eukaryot Cell. 2008 Sep;7(9):1513-7. doi: 10.1128/EC.00068-08. Epub 2008 Aug 1.

PMID:
18676958
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Tail chimeras of Dictyostelium myosin II support cytokinesis and other myosin II activities but not full development.

Shu S, Liu X, Parent CA, Uyeda TQ, Korn ED.

J Cell Sci. 2002 Nov 15;115(Pt 22):4237-49.

PMID:
12376556
[PubMed - indexed for MEDLINE]
Free Article
17.

Analysis of the regulatory phosphorylation site in Acanthamoeba myosin IC by using site-directed mutagenesis.

Wang ZY, Wang F, Sellers JR, Korn ED, Hammer JA 3rd.

Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15200-5.

PMID:
9860946
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Cellulose biosynthesis pathway is a potential target in the improved treatment of Acanthamoeba keratitis.

Dudley R, Alsam S, Khan NA.

Appl Microbiol Biotechnol. 2007 May;75(1):133-40. Epub 2007 Jan 16.

PMID:
17225099
[PubMed - indexed for MEDLINE]
19.

Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.

Bu Y, Yang Z, Li Q, Song F.

Oncology. 2008;74(3-4):198-206. doi: 10.1159/000151367. Epub 2008 Aug 20.

PMID:
18714168
[PubMed - indexed for MEDLINE]
20.

In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype.

Baig AM, Iqbal J, Khan NA.

Antimicrob Agents Chemother. 2013 Aug;57(8):3561-7. doi: 10.1128/AAC.00299-13. Epub 2013 May 13.

PMID:
23669391
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk